Corindus Vascular Robotics
CVRS
CVRS was delisted on the 28th of October, 2019.
81 hedge funds and large institutions have $259M invested in Corindus Vascular Robotics in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 14 closing their positions.
156% more capital inflows, than outflows
Capital inflows: $41.6M | Capital outflows: $16.3M
121% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 14
27% more funds holding
Funds holding: 64 → 81 (+17)
4.12% more ownership
Funds ownership: 38.08% → 42.2% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14.4M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$3.92M |
| 3 |
State Street
Boston,
Massachusetts
|
+$3.84M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.75M |
| 5 |
Millennium Management
New York
|
+$2.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.8M |
| 2 |
Bridgeway Capital Management
Houston,
Texas
|
-$1.59M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.29M |
| 4 |
Goldman Sachs
New York
|
-$1.03M |
| 5 |
Kennedy Capital Management
St Louis,
Missouri
|
-$1.01M |
CVRS Hedge Fund Activity: Q2 2019 in Review
81 of the 4,627 institutional investors tracked by Wall St. Rank reported a position in Corindus Vascular Robotics (CVRS) for Q2 2019, worth a combined $259M — up 90% from $136M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new CVRS positions and 14 closed out — a net gain of 17 holders — while 19 added to existing stakes and 21 trimmed.
The largest buyer was BlackRock, adding an estimated $14.4M. The largest seller was Fidelity Investments, exiting entirely with an estimated $6.8M sold.
- 81 institutional investors held Corindus Vascular Robotics (CVRS) as of Q2 2019, up from 64 in Q1 2019.
- Funds reported $259M of Corindus Vascular Robotics stock for Q2 2019, up 90% quarter-over-quarter.
- 31 funds opened new Corindus Vascular Robotics positions in Q2 2019 and 14 closed out, a net change of +17 holders.
- The largest Corindus Vascular Robotics buyer in Q2 2019 was BlackRock, an estimated $14.4M added.
- The largest Corindus Vascular Robotics seller in Q2 2019 was Fidelity Investments, an estimated $6.8M sold.
Based on aggregated 13F filings for Q2 2019.